9
Jun
De-risking Biologics: T-Cell Engager and Antibody-Protein Fusion Bispecific Case Studies
Jun 9, 2021
29
Apr
Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics
Apr 29, 2021

Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review

Collaboration with MIT - Published in Research and Practice in Thrombosis and Haemostasis

Subscribe to Other